Lung Cancer (NSCLC)

XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.

Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab Accumulation in HER2-mutated and HER2-overexpressing Metastatic Non-small Cell Lung Cancer

Construction and Empirical Study of Indirect Intervention Model for Protective Medical Lung Cancer Patients Based on Family System Theory

A Study of PHN-012 in Patients With Advanced Solid Tumors

Health for Hungary (H4H) - Longitudinal Collection of Blood Samples and Corresponding Data

Multi-Omics Prediction of Radiation Lung Injury in Immunotherapy-Treated Lung Cancer Patients

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

Preliminary Evaluation of a Large Language Model-Based Tool for Complex Surgical Decision Support in Lung Cancer

Navigation Bronchoscopy Guided Microwave Ablation Versus SBRT in Early NSCLC

Impact of Smoking Cessation Duration on Postoperative Complications in Lung Cancer Surgery

Furmonertinib Plus Radiotherapy for EGFR+ NSCLC With Pleural Effusion

Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC

Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1

First-line Therapy With EGFR-TKI Combined With Trastuzumab Rezetecan for Advanced NSCLC Harboring EGFR Mutations Concomitant With HER2 Alterations

SL-28 for Advanced Solid Tumours

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

Olomorasib + Pembrolizumab KRAS G12C Mutant, PD-L1 TPS 1-49% Locally Advanced or Metastatic NSCLC

GCC 2545- Improving Post-Radiotherapy Respiratory Function Through Sparing Serial and Parallel Components in the Lung

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02)

GCC 2546- Motion Management